atthemarket

Aptevo Therapeutics (NASDAQ:APVO) has entered into securities purchase agreements with certain investors to purchase 5.34M shares of its common stock or pre-funded warrants in lieu thereof and warrants to purchase up to an aggregate of 10.68M shares at $0.515 each, in a registered direct offering priced at-the-market under Nasdaq rules.Continue Reading